GlaxoSmithKline PLC

Symbol: GSK     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
4.80%
Current Price
$41.27
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 12:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
7,661,000,000
7,661,000,000
2,733,000,000
4,928,000,000
3,500,000,000
1,428,000,000
830,000,000
-
-
n.a.
-
4,419,000,000
-
-
-
372,000,000
663,000,000
 
1,006,000,000

Financials 2018

Update: 2019-06-09 12:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
8,197,000,000
8,197,000,000
2,904,000,000
5,293,000,000
2,158,000,000
3,135,000,000
1,215,000,000
16,927,000,000
58,066,000,000
54,394,000,000
4,360,000,000
4,087,000,000
5,793,000,000
3,958,000,000
26,064,000,000
460,000,000
4,119,000,000
 
1,076,000,000

Q 3

2018-09-30
8,092,000,000
8,092,000,000
2,636,000,000
5,456,000,000
3,546,000,000
1,910,000,000
1,418,000,000
17,418,000,000
58,604,000,000
54,881,000,000
4,476,000,000
3,587,000,000
2,902,000,000
3,873,000,000
27,710,000,000
-100,000,000
2,077,000,000
 
988,000,000

Q 2

2018-06-30
7,310,000,000
7,310,000,000
2,310,000,000
5,000,000,000
4,221,000,000
779,000,000
441,000,000
17,044,000,000
57,635,000,000
54,612,000,000
3,679,000,000
3,685,000,000
3,470,000,000
4,127,000,000
28,062,000,000
-90,000,000
1,362,000,000
 
925,000,000

Q 1

2018-03-31
7,222,000,000
7,222,000,000
2,391,000,000
4,831,000,000
3,591,000,000
1,240,000,000
549,000,000
-
-
n.a.
-
3,757,000,000
-
-
-
209,000,000
863,000,000
 
904,000,000

Financials 2017

Update: 2019-06-09 12:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
10,322,970,289
10,322,970,289
3,456,755,858
6,866,214,431
3,506,755,845
3,359,458,586
-737,837,646
21,495,940,357
76,190,520,731
71,475,657,092
-91,891,868
4,864,863,600
3,817,566,575
5,285,133,761
23,093,237,239
-977,026,773
3,877,026,019
 
1,633,783,359